American Vanguard Corp 2025 Earnings Report Analysis
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 12 hours ago
0mins
Should l Buy AVD?
Source: Yahoo Finance
- Sales Decline: Sales for 2025 reached $515 million, a 6% decrease year-over-year, primarily due to a 14% drop in international operations, reflecting the impact of elevated channel inventories in Mexico and drought conditions in Australia, which puts revenue pressure on the company.
- Adjusted EBITDA Growth: Adjusted EBITDA for 2025 was $39.2 million, slightly better than the previous year but below the target range of $40 million to $44 million, indicating the company's efforts in cost control and operational efficiency despite sluggish sales.
- Cost Savings Initiatives: The rationalization of the Los Angeles manufacturing facility and the relocation of headquarters are expected to save the company $4.5 million annually, enhancing financial flexibility and supporting future growth initiatives.
- New Product Revenue Expectations: The launch of new products is anticipated to contribute an additional $100 million in annual revenue over the medium term, primarily from new insecticides and herbicides, with a target to achieve this by 2030-2031, showcasing the company's strategic focus on product innovation.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AVD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AVD
About AVD
American Vanguard Corporation is a diversified specialty and agriculture products company, which develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. It conducts its business through its operating subsidiaries, including AMVAC Chemical Corporation (AMVAC) for its domestic business and AMVAC Netherlands BV (AMVAC BV) for its international business. AMVAC is a manufacturer of chemical, biological and biorational products that develops and markets solutions for agricultural, commercial and consumer uses. It synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection. These products, which include insecticides, fungicides, and biorationals, are marketed in liquid, powder, and granular forms. AMVAC BV sells products both directly and through its network of subsidiaries in various international territories.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Sales Decline: Sales for 2025 reached $515 million, a 6% decrease year-over-year, primarily due to a 14% drop in international operations, reflecting the impact of elevated channel inventories in Mexico and drought conditions in Australia, which puts revenue pressure on the company.
- Adjusted EBITDA Growth: Adjusted EBITDA for 2025 was $39.2 million, slightly better than the previous year but below the target range of $40 million to $44 million, indicating the company's efforts in cost control and operational efficiency despite sluggish sales.
- Cost Savings Initiatives: The rationalization of the Los Angeles manufacturing facility and the relocation of headquarters are expected to save the company $4.5 million annually, enhancing financial flexibility and supporting future growth initiatives.
- New Product Revenue Expectations: The launch of new products is anticipated to contribute an additional $100 million in annual revenue over the medium term, primarily from new insecticides and herbicides, with a target to achieve this by 2030-2031, showcasing the company's strategic focus on product innovation.
See More
- Earnings Performance: American Vanguard reported a FY 2025 GAAP EPS of -$1.75 and revenue of $515.11 million, reflecting a 5.9% year-over-year decline, indicating ongoing challenges in the market that may affect investor confidence moving forward.
- Adjusted EBITDA: The company achieved an adjusted EBITDA of $39.2 million, slightly above last year's $39.1 million, suggesting that it can maintain profitability under tough market conditions, but sluggish growth may limit future expansion opportunities.
- Future Outlook: American Vanguard anticipates adjusted EBITDA in the range of $44 to $48 million for 2026, indicating growth expectations; however, overcoming current market challenges will be crucial to achieving these targets, reflecting a cautious approach to future business development.
- Market Environment: Despite efforts to improve operations, the overall market environment remains challenging, which could impact the company's long-term strategy and market share, prompting investors to closely monitor its response strategies.
See More
- Earnings Report Schedule: American Vanguard will release its full-year financial results for 2025 on March 16, 2026, after market close, which is expected to provide investors with critical financial data and future outlook, aiding market assessment of the company's performance.
- Conference Call Details: The company will host an earnings conference call on the same day at 4:30 PM ET/1:30 PM PT, led by CEO Dak Kaye and CFO David T. Johnson, anticipated to provide in-depth analysis of the financial results and address investor questions.
- Webcast and Archiving: The conference call will be webcast on the company's website, and if investors are unable to listen live, the call will be archived for one year, enhancing transparency and accessibility of information for stakeholders.
- Company Background: American Vanguard Corporation is a diversified specialty and agriculture products company with over 1,000 product registrations worldwide, focusing on crop protection and management, turf and ornamental management, and public health, showcasing its extensive influence in the industry.
See More
- Stable Bond Market: Despite concerns over the U.S.-Iran tensions and rising oil prices, the bond market has held up well over the past week, with the 10-year Treasury yield remaining between 3.9% and 4.3%, indicating that fixed-income investments remain attractive.
- Underweight Fixed Income: Bob Michele from JPMorgan highlights that many investors have been under-allocated to fixed income over the past few years, leading to imbalanced portfolios, but there are signs that investors are now looking to the bond market for diversification.
- Increased Bond ETF Inflows: State Street reported that bond ETFs saw inflows of $52 billion in February, marking the second consecutive month above $50 billion, indicating a trend of investors seeking to diversify away from equities and enhance their fixed-income allocations.
- Emerging Market Appeal: Michele expresses optimism about emerging markets such as Mexico, Colombia, and Brazil, as well as Hungary, Romania, and Poland, noting that these markets offer high real yields of around 9%, which is attractive in an environment where central banks are effectively managing growth and inflation.
See More
Jobs Report Overview: The recent jobs report revealed troubling numbers that raised concerns about the state of the economy.
Market Reaction: The chaotic nature of the report led to significant volatility in the financial markets, reflecting investor uncertainty.
Economic Implications: Analysts are worried that the mixed signals from the jobs report could complicate future economic policies and decisions.
Public Perception: The report has contributed to a growing sense of unease among the public regarding job security and economic stability.
See More
- Market Volatility Impact: Concerns over the U.S.-Iran conflict have led to a projected 2% drop in the S&P 500 and a 3% decline in the Dow this week, prompting investors to seek more stable investment options, with municipal bonds gaining attention.
- Yield Attractiveness: Municipal bond yields have risen alongside Treasury fluctuations, and despite geopolitical risks, investors can lock in higher yields, particularly for those in higher tax brackets, where a 3.4% yield translates to a 5.8% tax-equivalent yield.
- Market Performance Recovery: The Bloomberg Municipal Bond Index has gained approximately 1.5% year-to-date, outperforming the less than 1% return of the Bloomberg U.S. Aggregate Bond Index, indicating strong demand and reduced supply driving market recovery.
- Investment Strategy Recommendations: Experts suggest investors adopt a barbell strategy that combines short-term and long-term bonds to maximize flexibility and returns while preparing for potential market volatility, ensuring portfolio stability.
See More










